» Articles » PMID: 36935582

Nomogram for Predicting 90-day Mortality in Patients with -caused Hospital-acquired and Ventilator-associated Pneumonia in the Respiratory Intensive Care Unit

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2023 Mar 20
PMID 36935582
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We built a prediction model of mortality risk in patients the with (AB)-caused hospital-acquired (HAP) and ventilator-associated pneumonia (VAP).

Methods: In this retrospective study, 164 patients with AB lower respiratory tract infection were admitted to the respiratory intensive care unit (RICU) from January 2019 to August 2021 (29 with HAP, 135 with VAP) and grouped randomly into a training cohort (n = 115) and a validation cohort (n = 49). Least absolute shrinkage and selection operator regression and multivariate Cox regression were used to identify risk factors of 90-day mortality. We built a nomogram prediction model and evaluated model discrimination and calibration using the area under the receiver operating characteristic curve (AUC) and calibration curves, respectively.

Results: Four predictors (days in intensive care unit, infection with carbapenem-resistant AB, days of carbapenem use within 90 days of isolating AB, and septic shock) were used to build the nomogram. The AUC of the two groups was 0.922 and 0.823, respectively. The predictive model was well-calibrated; decision curve analysis showed the proposed nomogram would obtain a net benefit with threshold probability between 1% and 100%.

Conclusions: The nomogram model showed good performance, making it useful in managing patients with AB-caused HAP and VAP.

Citing Articles

Handwashing sinks as reservoirs of carbapenem-resistant in the intensive care unit: a prospective multicenter study.

Wei L, Feng Y, Lin J, Kang X, Zhuang H, Wen H Front Public Health. 2024; 12:1468521.

PMID: 39444981 PMC: 11496070. DOI: 10.3389/fpubh.2024.1468521.


A Machine Learning Model Based on CT Imaging Metrics and Clinical Features to Predict the Risk of Hospital-Acquired Pneumonia After Traumatic Brain Injury.

Li S, Feng Q, Wang J, Wu B, Qiu W, Zhuang Y Infect Drug Resist. 2024; 17:3863-3877.

PMID: 39253609 PMC: 11382661. DOI: 10.2147/IDR.S473825.


Investigating the Effectiveness of Ceragenins against to Develop New Antimicrobial and Anti-Adhesive Strategies.

Karasinski M, Wnorowska U, Daniluk T, Deptula P, Luckiewicz M, Paprocka P Int J Mol Sci. 2024; 25(13).

PMID: 39000144 PMC: 11241064. DOI: 10.3390/ijms25137036.


Treatment and Management of Pneumonia: Lessons Learned from Recent World Event.

Rangel K, De-Simone S Infect Drug Resist. 2024; 17:507-529.

PMID: 38348231 PMC: 10860873. DOI: 10.2147/IDR.S431525.

References
1.
Langelier C, Kalantar K, Moazed F, Wilson M, Crawford E, Deiss T . Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc Natl Acad Sci U S A. 2018; 115(52):E12353-E12362. PMC: 6310811. DOI: 10.1073/pnas.1809700115. View

2.
Lim S, Zainal Abidin A, Liew S, Roberts J, Sime F . The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect. 2019; 79(6):593-600. DOI: 10.1016/j.jinf.2019.09.012. View

3.
Ozgur E, Horasan E, Karaca K, Ersoz G, Nayci Atis S, Kaya A . Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control. 2014; 42(2):206-8. DOI: 10.1016/j.ajic.2013.09.003. View

4.
. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

5.
Paglicci L, Borgo V, Lanzarone N, Fabbiani M, Cassol C, Cusi M . Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients. Eur J Clin Microbiol Infect Dis. 2021; 40(6):1271-1282. PMC: 8139905. DOI: 10.1007/s10096-021-04153-1. View